Cargando…
Identification of Novel Intronic SNPs in Transporter Genes Associated with Metformin Side Effects
Metformin is a widely used and effective medication in type 2 diabetes (T2DM) as well as in polycystic ovary syndrome (PCOS). Single nucleotide polymorphisms (SNPs) contribute to the occurrence of metformin side effects. The aim of the present study was to identify intronic genetic variants modifyin...
Autores principales: | Schweighofer, Natascha, Strasser, Moritz, Obermayer, Anna, Trummer, Olivia, Sourij, Harald, Sourij, Caren, Obermayer-Pietsch, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454417/ https://www.ncbi.nlm.nih.gov/pubmed/37628660 http://dx.doi.org/10.3390/genes14081609 |
Ejemplares similares
-
Intronic Variants in OCT1 are Associated with All-Cause and Cardiovascular Mortality in Metformin Users with Type 2 Diabetes
por: Schweighofer, Natascha, et al.
Publicado: (2020) -
INTERmittent FASTing in people with insulin‐treated type 2 diabetes mellitus – the INTERFAST‐2 study protocol
por: Obermayer, Anna, et al.
Publicado: (2022) -
Graz Endocrine Causes of Hypertension (GECOH) study: a diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronism
por: Pilz, Stefan, et al.
Publicado: (2009) -
Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)—A Randomized Controlled Trial
por: Obermayer, Anna, et al.
Publicado: (2023) -
Performance of the Intermittently Scanned Continuous Glucose Monitoring (isCGM) System during a High Oral Glucose Challenge in Adults with Type 1 Diabetes—A Prospective Secondary Outcome Analysis
por: Moser, Othmar, et al.
Publicado: (2021)